Delving into the Latest Updates on Myogem Health Co. SL with Synapse

概览

关联

1

项与 Myogem Health Co. SL 相关的临床试验

NCT04634682

/ CompletedN/A

Assessing the Effect of the MYODM Food Supplement on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

The purpose of this study is to determine whether MYODM (formulated composition containing Theobroma cacao supplemented with caffeine (caffeine/theobromine ratio1/1.85, w/w) is effective in the treatment of excessive daytime sleepiness due to myotonic dystrophy type 1 (DM1) and improves the quality of life of these patients.

开始日期2020-11-09

申办/合作机构

Myogem Health Co. SL

100 项与 Myogem Health Co. SL 相关的临床结果

登录后查看更多信息

0 项与 Myogem Health Co. SL 相关的专利（医药）

登录后查看更多信息

100 项与 Myogem Health Co. SL 相关的药物交易

登录后查看更多信息

100 项与 Myogem Health Co. SL 相关的转化医学

登录后查看更多信息